These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37319284)

  • 1. Disease parameters following ocular herpes simplex virus type 1 infection are similar in male and female BALB/C mice.
    Kolb AW; Ferguson SA; Larsen IV; Brandt CR
    PLoS One; 2023; 18(6):e0287194. PubMed ID: 37319284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Sex Differences in Ocular Herpes Simplex Virus 1 Infection and Herpes Stromal Keratitis Pathogenesis of Wild-Type and Herpesvirus Entry Mediator Knockout Mice.
    Riccio RE; Park SJ; Longnecker R; Kopp SJ
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30918059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo.
    Mott KR; Wechsler SL; Ghiasi H
    Mol Vis; 2010 Oct; 16():2153-62. PubMed ID: 21139679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains.
    Kintner RL; Allan RW; Brandt CR
    Arch Virol; 1995; 140(2):231-44. PubMed ID: 7710352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
    Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
    Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
    Osorio Y; Ghiasi H
    J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.
    Keadle TL; Morrison LA; Morris JL; Pepose JS; Stuart PM
    J Virol; 2002 Apr; 76(8):3615-25. PubMed ID: 11907201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the Herpes Simplex Virus 1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US Regions.
    Lee K; Kolb AW; Larsen I; Craven M; Brandt CR
    J Virol; 2016 Sep; 90(18):8115-31. PubMed ID: 27384650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence.
    Kolb AW; Lee K; Larsen I; Craven M; Brandt CR
    PLoS Pathog; 2016 Mar; 12(3):e1005499. PubMed ID: 26962864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of STAT4 in IgG subtype switching and ocular HSV-1 replication in mice.
    Allen SJ; Mott KR; Ghiasi H
    Mol Vis; 2010 Jan; 16():98-104. PubMed ID: 20104254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes Simplex Virus 1 Replication, Ocular Disease, and Reactivations from Latency Are Restricted Unilaterally after Inoculation of Virus into the Lip.
    Poccardi N; Rousseau A; Haigh O; Takissian J; Naas T; Deback C; Trouillaud L; Issa M; Roubille S; Juillard F; Efstathiou S; Lomonte P; Labetoulle M
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in mice.
    Mott KR; Zandian M; Allen SJ; Ghiasi H
    J Virol; 2013 Nov; 87(22):12102-9. PubMed ID: 23986600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpesvirus Entry Mediator Binding Partners Mediate Immunopathogenesis of Ocular Herpes Simplex Virus 1 Infection.
    Park SJ; Riccio RE; Kopp SJ; Ifergan I; Miller SD; Longnecker R
    mBio; 2020 May; 11(3):. PubMed ID: 32398314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus.
    Ramsey NLM; Visciano M; Hunte R; Loh LN; Burn Aschner C; Jacobs WR; Herold BC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An M2 Rather than a T
    Lee DH; Ghiasi H
    J Virol; 2018 May; 92(10):. PubMed ID: 29491152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD80 Plays a Critical Role in Increased Inflammatory Responses in Herpes Simplex Virus 1-Infected Mouse Corneas.
    Tormanen K; Wang S; Ghiasi H
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31619558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent enhancement of HSV-1 infection by anti-gK sera.
    Ghiasi H; Perng GC; Nesburn AB; Wechsler SL
    Virus Res; 2000 Jul; 68(2):137-44. PubMed ID: 10958985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
    Morrison LA; Knipe DM
    J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple determinants contribute to the virulence of HSV ocular and CNS infection and identification of serine 34 of the US1 gene as an ocular disease determinant.
    Brandt CR; Kolb AW; Shah DD; Pumfery AM; Kintner RL; Jaehnig E; Van Gompel JJ
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2657-68. PubMed ID: 12766070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.